Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rani Therapeutics Inc.

    NASDAQ: RANI · Real-Time Price · USD
    0.52
    -0.00 (-0.02%)
    At close: Jun 17, 2025, 3:59 PM
    0.52
    0.06%
    After-hours: Jun 17, 2025, 07:58 PM EDT

    Rani Therapeutics Statistics

    Share Statistics

    Rani Therapeutics has 57.54M shares outstanding. The number of shares has increased by 13.62% in one year.

    Shares Outstanding

    n/a
    		 57.54M

    Shares Change (YoY)

    n/a
    		 13.62%

    Shares Change (QoQ)

    n/a
    		 -0.24%

    Owned by Institutions (%)

    n/a
    		 13.25%

    Shares Floating

    n/a
    		 39.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 11,136

    FTD / Avg. Volume

    n/a
    		 2.62%

    Short Selling Information

    The latest short interest is 3.11M, so 9.27% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.11M

    Short % of Shares Out

    n/a
    		 9.27%

    Short % of Float

    n/a
    		 13.1%

    Short Ratio (days to cover)

    n/a
    		 5.13

    Valuation Ratios

    The PE ratio is -1.3 and the forward PE ratio is -0.68. Rani Therapeutics's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -1.3

    Forward PE

    n/a
    		 -0.68

    PS Ratio

    n/a
    		 37.95

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 19.58

    P/FCF Ratio

    n/a
    		 -1.09

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Rani Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.5, with a Debt / Equity ratio of 14.91.

    Current Ratio

    n/a
    		 1.5

    Quick Ratio

    n/a
    		 1.5

    Debt / Equity

    n/a
    		 14.91

    Debt / EBITDA

    n/a
    		 -0.59

    Debt / FCF

    n/a
    		 -0.83

    Interest Coverage

    n/a
    		 -10.59

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $9,790.48

    Profits Per Employee

    n/a
    		 $-285,885.71

    Employee Count

    n/a
    		 105

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 26.57M

    Effective Tax Rate

    n/a
    		 -88.5%

    Stock Price Statistics

    The stock price has increased by -86.63% in the last 52 weeks. The beta is 0, so Rani Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 -86.63%

    50-Day Moving Average

    n/a
    		 0.83

    200-Day Moving Average

    n/a
    		 1.62

    Relative Strength Index (RSI)

    n/a
    		 31.12

    Average Volume (20 Days)

    n/a
    		 425,420

    Income Statement

    In the last 12 months, Rani Therapeutics had revenue of 1.03M and earned -30.02M in profits. Earnings per share was -1.05.

    Revenue

    n/a
    		 1.03M

    Gross Profit

    n/a
    		 1.03M

    Operating Income

    n/a
    		 -53.31M

    Net Income

    n/a
    		 -30.02M

    EBITDA

    n/a
    		 -50.52M

    EBIT

    n/a
    		 -51.55M

    Earnings Per Share (EPS)

    n/a
    		 -1.05
    Full Income Statement

    Balance Sheet

    The company has 3.76M in cash and 29.71M in debt, giving a net cash position of -25.95M.

    Cash & Cash Equivalents

    n/a
    		 3.76M

    Total Debt

    n/a
    		 29.71M

    Net Cash

    n/a
    		 -25.95M

    Retained Earnings

    n/a
    		 -102.91M

    Total Assets

    n/a
    		 24.13M

    Working Capital

    n/a
    		 -2.35M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -35.5M and capital expenditures -268K, giving a free cash flow of -35.76M.

    Operating Cash Flow

    n/a
    		 -35.5M

    Capital Expenditures

    n/a
    		 -268K

    Free Cash Flow

    n/a
    		 -35.76M

    FCF Per Share

    n/a
    		 -1.26
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -5186.19% and -2920.04%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -5186.19%

    Pretax Margin

    n/a
    		 -2920.04%

    Profit Margin

    n/a
    		 -2920.04%

    EBITDA Margin

    n/a
    		 -4914.69%

    EBIT Margin

    n/a
    		 -5186.19%

    FCF Margin

    n/a
    		 -3478.99%

    Dividends & Yields

    RANI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for RANI is $9, which is 1630.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 1630.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -12.64

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist